Skip to main content
1491 results

PBPK Applications (MIFD) Using the Simcyp Simulator eBook

EBOOK PBPK Applications (MIFD) Using the Simcyp™ Simulator Welcome the Future of Biopharmaceutics Explore strategies, regulatory validation, and solutions through case studies in small-molecule human Physiologically Based Pharmacokinetic modeling (PBPK). Submit the form below to download your exclusive copy of the eBook and shape the future of pharmaceutical innovation! What you’ll learn How PBPK modeling … Continued

https://www.certara.com/pbpk-applications-mifd-using-the-simcyp-simulator/

Thank You – PBPK Applications (MIFD) Using the Simcyp™ Simulator ebook

How about a free demo of the Simcyp™ PBPK Simulator? Complete the form to book your no-obligation demo of the standard software for Population-based Physiologically Based Modeling and Simulation… and see how better off you could be with Simcyp!

https://www.certara.com/thank-you-pbpk-applications-mifd-using-the-simcyp-simulator-ebook/

Certara Talks: ISPOR Europe 2023

Join us in this episode of CertaraTalks as Roman Casciano and Ananth Kadambi discuss the key highlights from ISPOR Europe 2023. Watch below for insights and key takeaways around topics like the European health data space and the use of AI for health technology assessment. Transcript Hello, and welcome to Certara Talks. I’m Doctor Suzanne … Continued

https://www.certara.com/podcast/certara-talks-ispor-europe-2023/

Certara Talks: ACoP 2023 Recap

The latest episode of CertaraTalks features Dr. Mirjam Trame and Dr. Piet van der Graaf being interviewed by Dr. Suzanne Minton on the key moments from the annual meeting of the American Conference on Pharmacometrics, ACoP14! Explore highlights ranging from the dynamic ISOP Trainee Communications Challenge to the groundbreaking use of ArtificialIntelligence in Quantitative Systems … Continued

https://www.certara.com/podcast/certara-talks-acop-2023-recap/

Certara Talks: ACT 2023 Recap

In the latest CertaraTalks episode, Krista K. Greenwood, PhD, DABT, Director of Toxicology at Certara, shares key insights from the American College of Toxicology 2023 Annual Meeting. Explore highlights like Project Optimus, the FDA’s groundbreaking dose optimization initiative for oncology products, and updates on the latest safety pharmacology best practices. Transcript: Introduction Welcome. You’re watching … Continued

https://www.certara.com/podcast/certara-talks-act-2023-recap/

Certara Talks: AMWA 2023

Laura Sheppard joins this episode of #CertaraTalks to share highlights from #AMWA2023. Watch below for insights and key takeaways around topics like AI and the evolution of technology in medical writing and the importance of plain language summaries. Video Transcript: Hello, everybody. I’m Doctor. Suzanne Minton. I’m a director of content strategy at Sartara, and … Continued

https://www.certara.com/podcast/certara-talks-amwa-2023/

Certara to Report Fourth Quarter and Full Year 2023 Financial Results on February 29th, 2024 and Participate in the Barclays 26th Annual Global Healthcare Conference

PRINCETON, N.J., Feb. 01, 2024 (GLOBE NEWSWIRE) — Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that it will release financial results for the fourth quarter and full year of 2023 after the market close on Thursday, February 29th, 2024. Company management will host a conference call to discuss financial results at … Continued

https://www.certara.com/pressrelease/certara-to-report-fourth-quarter-and-full-year-2023-financial-results-on-february-29th-2024-and-participate-in-the-barclays-26th-annual-global-healthcare-conference/

How to Obtain Market Access and Reimbursement in the United States, France and Germany 【APAC Webinar】

The educational webinar will present the process of obtaining market access and reimbursement in the US, France and Germany as well as on the upcoming a Joint Clinical Assessment (JCA) process. In the US, we will be discussing the stakeholders that are involved in product access given the fragmented US payer system (e.g. Commercial, Medicare, … Continued

https://www.certara.com/on-demand-webinar/how-to-obtain-market-access-and-reimbursement-in-the-united-states-france-and-germany/

[Voice of Customer Article] Chinese CRO, Zhejiang Longcharm Biomedical Technology, Optimizes Sponsors’Non-clinical & Clinical Regulatory Review Processes with Pinnacle 21 Enterprise

Authors: Liming Fang, Emi Akatsu, Phillip Johnston Founded in 2016, Zhejiang Longcharm Biomedicine Technology Co., Ltd. provides one-stop R&D outsourcing services for the Chinese pharmaceutical industry. They can support BA/BE/PK clinical testing and data analysis services that comply with Chinese and American regulatory requirements for both novel and generic drug development programs. In 2023 July, … Continued

https://www.certara.com/article/voice-of-customer-article-chinese-cro-zhejiang-longcharm-biomedical-technology-optimizes-sponsorsnon-clinical-clinical-regulatory-review-processes-with-pinnacle-21-enterprise/
9 of 150